<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37085072</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0003</ISSN><JournalIssue CitedMedium="Internet"><Volume>241</Volume><PubDate><Year>2023</Year><Month>Jun</Month><Day>30</Day></PubDate></JournalIssue><Title>International journal of biological macromolecules</Title><ISOAbbreviation>Int J Biol Macromol</ISOAbbreviation></Journal><ArticleTitle>Effect of proteins isolated from Brazilian snakes on enterovirus A71 replication cycle: An approach against hand, foot and mouth disease.</ArticleTitle><Pagination><StartPage>124519</StartPage><MedlinePgn>124519</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijbiomac.2023.124519</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0141-8130(23)01413-7</ELocationID><Abstract><AbstractText>Enterovirus A71 (EVA71) belongs to the Picornaviridae family and is the main etiological agent of hand, foot, and mouth disease (HFMD). There is no approved antiviral against EVA71, and therefore the search for novel anti-EVA71 therapeutics is essential. In this context, the antiviral activity of proteins isolated from snake venoms has been reported against a range of viruses. Here, the proteins CM10 and CM14 isolated from Bothrops moojeni, and Crotamin and PLA2<sub>CB</sub> isolated from Crotalus durissus terrificus were investigated for their antiviral activity against EVA71 infection. CM14 and Crotamin possessed a selective index (SI) of 170.8 and 120.4, respectively, while CM10 and PLA2<sub>CB</sub> had an SI of 67.4 and 12.5, respectively. CM14 inhibited all steps of viral replication (protective effect: 76 %; virucidal: 99 %; and post-entry: 99 %). Similarly, Crotamin inhibited up to 99 % of three steps. In contrast, CM10 and PLA2<sub>CB</sub> impaired one or two steps of EVA71 replication, respectively. Further dose-response assays using increasing titres of EVA71 were performed and CM14 and Crotamin retained functionality with high concentrations of EVA71 (up to 1000 TCID<sub>50</sub>). These data demonstrate that proteins isolated from snake venom are potent inhibitors of EVA71 and could be used as scaffolds for future development of novel antivirals.</AbstractText><CopyrightInformation>Copyright © 2023 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Jacqueline Farinha</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Laboratory of Antiviral Research, Institute of Biomedical Science - ICBIM, Federal University of Uberlândia - UFU, Uberlândia, MG, Brazil; Institute of Biosciences, Language and Exact Science - IBILCE, São Paulo State University - UNESP, São José do Rio Preto, SP, Brazil; Brazilian Biosciences National Laboratory (LNBio), Brazilian Centre for Research in Energy and Materials (CNPEM), Campinas, SP 13083-100, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feferbaum-Leite</LastName><ForeName>Shiraz</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Antiviral Research, Institute of Biomedical Science - ICBIM, Federal University of Uberlândia - UFU, Uberlândia, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Igor Andrade</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Laboratory of Antiviral Research, Institute of Biomedical Science - ICBIM, Federal University of Uberlândia - UFU, Uberlândia, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Daniel Oliveira Silva</ForeName><Initials>DOS</Initials><AffiliationInfo><Affiliation>Laboratory of Antiviral Research, Institute of Biomedical Science - ICBIM, Federal University of Uberlândia - UFU, Uberlândia, MG, Brazil; Institute of Biosciences, Language and Exact Science - IBILCE, São Paulo State University - UNESP, São José do Rio Preto, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kingston</LastName><ForeName>Natalie J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shegdar</LastName><ForeName>Mona</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zothner</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sampaio</LastName><ForeName>Suely Vilela</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo - USP, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stonehouse</LastName><ForeName>Nicola J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jardim</LastName><ForeName>Ana Carolina Gomes</ForeName><Initials>ACG</Initials><AffiliationInfo><Affiliation>Laboratory of Antiviral Research, Institute of Biomedical Science - ICBIM, Federal University of Uberlândia - UFU, Uberlândia, MG, Brazil; Institute of Biosciences, Language and Exact Science - IBILCE, São Paulo State University - UNESP, São José do Rio Preto, SP, Brazil. Electronic address: jardim@ufu.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>096670</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/P022626/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S001026/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Biol Macromol</MedlineTA><NlmUniqueID>7909578</NlmUniqueID><ISSNLinking>0141-8130</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003435">Crotalid Venoms</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.1.4</RegistryNumber><NameOfSubstance UI="D054467">Phospholipases A2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003435" MajorTopicYN="Y">Crotalid Venoms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012911" MajorTopicYN="N">Snakes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054467" MajorTopicYN="N">Phospholipases A2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiviral</Keyword><Keyword MajorTopicYN="N">Brazilian snakes</Keyword><Keyword MajorTopicYN="N">EVA71</Keyword><Keyword MajorTopicYN="N">Enterovirus A71</Keyword><Keyword MajorTopicYN="N">Toxins</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>22</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>19</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37085072</ArticleId><ArticleId IdType="mid">EMS194312</ArticleId><ArticleId IdType="pmc">PMC7615699</ArticleId><ArticleId IdType="doi">10.1016/j.ijbiomac.2023.124519</ArticleId><ArticleId IdType="pii">S0141-8130(23)01413-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lee KY. Enterovirus 71 infection and neurological complications. Korean J Pediatr. 2016 doi: 10.3345/kjp.2016.59.10.395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/kjp.2016.59.10.395</ArticleId><ArticleId IdType="pmc">PMC5099286</ArticleId><ArticleId IdType="pubmed">27826325</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, MacDonald NE, Smith JC, Cai K, Yu H, Li H, Lei C. Severe enterovirus type 71 nervous system infections in children in the Shanghai region of China: clinical manifestations and implications for prevention and care. Pediatr Infect Dis J. 2014 doi: 10.1097/INF.0000000000000194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000000194</ArticleId><ArticleId IdType="pubmed">24732390</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA, Gauntt CJ, Sakkinen P. Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity. 1998 doi: 10.1016/s0065-3527(08)60783-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0065-3527(08)60783-6</ArticleId><ArticleId IdType="pubmed">9891585</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong V, Mey C, Eloit M, Zhu H, Danet L, Huang Z, Zou G, Tarantola A, Cheval J, Perot P, Laurent D, et al. Molecular epidemiology of human enterovirus 71 at the origin of an epidemic of fatal hand, foot and mouth disease cases in Cambodia, Emerg. Microbes Infect. 2016;5:1–9. doi: 10.1038/emi.2016.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2016.101</ArticleId><ArticleId IdType="pmc">PMC5113052</ArticleId><ArticleId IdType="pubmed">27651091</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Burakoff A, Nix WA, Rogers S, Oberste MS, Gerber SI, Spence Davizon E, Herlihy R, Dominguez SR. Notes from the field: enterovirus A71 neurologic disease in children — Colorado, 2018. MMWR Morb Mortal Wkly Rep. 2018;67:1017–1018. doi: 10.15585/mmwr.mm6736a5.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6736a5</ArticleId><ArticleId IdType="pmc">PMC6146947</ArticleId><ArticleId IdType="pubmed">30212441</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Pallansch MA. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 1995;39:195–205. doi: 10.1016/0168-1702(95)00087-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(95)00087-9</ArticleId><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974 doi: 10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Belsham GJ, Sonenberg N. RNA-protein interactions in regulation of picornavirus RNA translation. Microbiol Rev. 1996;60:499–511. doi: 10.1128/MMBR.60.3.499-511.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.60.3.499-511.1996</ArticleId><ArticleId IdType="pmc">PMC239454</ArticleId><ArticleId IdType="pubmed">8840784</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimmer E, Hellen CUT, Cao X. Genetics of poliovirus. Annu Rev Genet. 1993;27:353–436. doi: 10.1146/annurev.ge.27.120193.002033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.ge.27.120193.002033</ArticleId><ArticleId IdType="pubmed">8122908</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Lai JKF, Sam IC, Chan YF. Recent developments in antiviral agents against enterovirus 71 infection. J Biomed Sci. 2014;21:1–11. doi: 10.1186/1423-0127-21-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-14</ArticleId><ArticleId IdType="pmc">PMC3924904</ArticleId><ArticleId IdType="pubmed">24521134</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J, Shen L, Wu J, Zou X, Gu J, Chen J, Mao L. Enterovirus A71 proteins: structure and function. Front Microbiol. 2018;9:1–12. doi: 10.3389/fmicb.2018.00286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.00286</ArticleId><ArticleId IdType="pmc">PMC5826392</ArticleId><ArticleId IdType="pubmed">29515559</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KT, Chang HL, Wang ST, Cheng YT, Yang JY. Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998−2005. Pediatrics. 2007;120:1998–2005. doi: 10.1542/peds.2006-3331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2006-3331</ArticleId><ArticleId IdType="pubmed">17671037</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang XF, Lu J, Liu XX, Dai T. Epidemiological features of hand, foot and mouth disease outbreaks among Chinese preschool children: a meta-analysis, Iran. J Public Health. 2018;47:1234–1243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6174039</ArticleId><ArticleId IdType="pubmed">30319997</ArticleId></ArticleIdList></Reference><Reference><Citation>Muehlenbachs A, Bhatnagar J, Zaki SR. Tissue tropism, pathology and pathogenesis of enterovirus infection. J Pathol. 2015;235:217–228. doi: 10.1002/path.4438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4438</ArticleId><ArticleId IdType="pubmed">25211036</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro CMO, Cruz ACR, Da Silva EE, Gomes MDLC. Molecular and seroepidemiologic studies of enterovirus 71 infection in the state of Pará, Brazil. Rev Inst Med Trop Sao Paulo. 2005;47:65–71. doi: 10.1590/s0036-46652005000200002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0036-46652005000200002</ArticleId><ArticleId IdType="pubmed">15880216</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010 doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang YK, Chen KH, Chen KT. Hand, foot and mouth disease and herpangina caused by enterovirus a71 infections: a review of enterovirus a71 molecular epidemiology, pathogenesis, and current vaccine development. Rev Inst Med Trop Sao Paulo. 2018;60:1–8. doi: 10.1590/s1678-9946201860070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s1678-9946201860070</ArticleId><ArticleId IdType="pmc">PMC6223252</ArticleId><ArticleId IdType="pubmed">30427405</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee TC, Guo HR, Su HJJ, Yang YC, Chang HL, Chen KT. Diseases caused by enterovirus 71 infection. Pediatr Infect Dis J. 2009 doi: 10.1097/INF.0b013e3181a41d63.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e3181a41d63</ArticleId><ArticleId IdType="pubmed">20118685</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Burakoff A, Nix WA, Rogers S, Oberste MS, Gerber SI, Spence-Davizon E, Herlihy R, Dominguez SR. Notes from the field: enterovirus A71 neurologic disease in children — Colorado, 2018. MMWR Morb Mortal Wkly Rep. 2018;67:1017–1018. doi: 10.15585/mmwr.mm6736a5.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6736a5</ArticleId><ArticleId IdType="pmc">PMC6146947</ArticleId><ArticleId IdType="pubmed">30212441</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zou G, Xia A, Wang X, Cai J, Gao Q, Yuan S, He G, Zhang S, Zeng M, Altmeyer R. Enterovirus 71 infection in children with hand, foot, and mouth disease in Shanghai, China: epidemiology, clinical feature and diagnosis positive-strand RNA viruses. Virol J. 2015 doi: 10.1186/s12985-015-0308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0308-2</ArticleId><ArticleId IdType="pmc">PMC4464242</ArticleId><ArticleId IdType="pubmed">26036928</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu Y, Luo L, Rui J, Yang S, Deng B, Zhao Z, Lin S, Xu J, Zhu Y, Wang Y, Yang M, et al. Control measures during the COVID-19 outbreak reduced the transmission of hand, foot, and mouth disease. JSafSciResilience. 2021;2:63–68. doi: 10.1016/j.jnlssr.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnlssr.2021.06.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Rui J, Cheng X, Deng B, Zhang H, Huang L, Zhang L, Zuo S, Li J, Huang X, Su Y, et al. Transmissibility of hand, foot, and mouth disease in 97 counties of China. Sci Rep. 2022;12:4103. doi: 10.1038/s41598-022-07982-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07982-y</ArticleId><ArticleId IdType="pmc">PMC8902910</ArticleId><ArticleId IdType="pubmed">35260706</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ML, Shih SR, Tolbert BS, Brewer G. Enterovirus a71 vaccines. Vaccines. 2021;9:1–10. doi: 10.3390/vaccines9030199.Basel.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9030199.Basel</ArticleId><ArticleId IdType="pmc">PMC7997495</ArticleId><ArticleId IdType="pubmed">33673595</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi E-J, Shin Y-J, Kim J-H, Kim T-G, Chang S-Y. Enterovirus 71 infection and vaccines. Clin Exp Vaccine Res. 2017;6:4. doi: 10.7774/cevr.2017.6.1.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2017.6.1.4</ArticleId><ArticleId IdType="pmc">PMC5292356</ArticleId><ArticleId IdType="pubmed">28168168</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YM, Wang X, Wang JZ, Wang L, Zhang YJ, Chang L, Liang ZL, Xia JL, Dai QG, Hu YL, Mao QY, et al. Immunogenicity, safety, and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6 to 59 months. Clin Vaccine Immunol. 2013;20:1805–1811. doi: 10.1128/CVI.00491-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00491-13</ArticleId><ArticleId IdType="pmc">PMC3889509</ArticleId><ArticleId IdType="pubmed">24108780</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Q, He F, Kwang J. Recent progress towards novel EV71 anti-therapeutics and vaccines. Viruses. 2015;7:6441–6457. doi: 10.3390/v7122949.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122949</ArticleId><ArticleId IdType="pmc">PMC4690872</ArticleId><ArticleId IdType="pubmed">26670245</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, Tan X, Wang L, Mao Q, Wu J, Hu Y, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370:818–828. doi: 10.1056/nejmoa1304923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa1304923</ArticleId><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Samy RP, Gopalakrishnakone P, Stiles BG, Girish KS, Swamy SN, Hemshekhar M, Tan KS, Rowan EG, Sethi G, Chow VTK. Snake venom phospholipases A2: a novel tool against bacterial diseases. Curr Med Chem. 2012;19:6150–6162. doi: 10.2174/092986712804485791.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986712804485791</ArticleId><ArticleId IdType="pubmed">22963667</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh CY, Kini RM. From snake venom toxins to therapeutics - cardiovascular examples. Toxicon. 2012;59:497–506. doi: 10.1016/j.toxicon.2011.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxicon.2011.03.017</ArticleId><ArticleId IdType="pubmed">21447352</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas A, Gomes A, Sengupta J, Datta P, Singha S, Dasgupta AK, Gomes A. Nanoparticle-conjugated animal venom-toxins and their possible therapeutic potential. J Venom Res. 2012;3:15–21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3518302</ArticleId><ArticleId IdType="pubmed">23236583</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilas Boas LCP, Campos ML, Berlanda RLA, de Carvalho Neves N, Franco OL. Antiviral peptides as promising therapeutic drugs. Cell Mol Life Sci. 2019 doi: 10.1007/s00018-019-03138-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03138-w</ArticleId><ArticleId IdType="pmc">PMC7079787</ArticleId><ArticleId IdType="pubmed">31101936</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu JF, Pereira CM, Bittar C, Batista MN, Campos GRF, da Silva S, Cintra ACO, Zothner C, Harris M, Sampaio SV, Aquino VH, et al. Multiple effects of toxins isolated from Crotalus durissus terrificus on the hepatitis C virus life cycle. PLoS One. 2017;12:e0187857. doi: 10.1371/journal.pone.0187857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0187857</ArticleId><ArticleId IdType="pmc">PMC5687739</ArticleId><ArticleId IdType="pubmed">29141010</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller VD, Soares RO, Dos Santos-Junior NN, Trabuco AC, Cintra AC, Figueiredo LT, Caliri A, Sampaio SV, Aquino VH. Phospholipase A2 isolated from the venom of Crotalus durissus terrificus inactivates dengue virus and other enveloped viruses by disrupting the viral envelope. PLoS One. 2014;9:1–10. doi: 10.1371/journal.pone.0112351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0112351</ArticleId><ArticleId IdType="pmc">PMC4226559</ArticleId><ArticleId IdType="pubmed">25383618</ArticleId></ArticleIdList></Reference><Reference><Citation>Petricevich Vera L, Mendonça Ronaldo Z. Inhibitory potential of Crotalus durissus terrificus venom on measles virus growth. Toxicon. 2003;42:143–153. doi: 10.1016/S0041-0101(03)00124-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0041-0101(03)00124-7</ArticleId><ArticleId IdType="pubmed">12906885</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos IA, Shimizu JF, de Oliveira DM, Martins DOS, Cardoso-Sousa L, Cintra ACO, Aquino VH, Sampaio SV, Nicolau-Junior N, Sabino-Silva R, Merits A, et al. Chikungunya virus entry is strongly inhibited by phospholipase A2 isolated from the venom of Crotalus durissus terrificus. Sci Rep. 2021;11:8717. doi: 10.1038/s41598-021-88039-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88039-4</ArticleId><ArticleId IdType="pmc">PMC8062466</ArticleId><ArticleId IdType="pubmed">33888774</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassani NM, Santos IA, Grosche VR, Ferreira GM, Guevara-Vega M, Rosa RB, Pena LJ, Nicolau-Junior N, Cintra ACO, Mineo TP, Sabino-Silva R, et al. Roles of Bothrops jararacussu toxins I and II: antiviral findings against zika virus. Int J Biol Macromol. 2023;227:630–640. doi: 10.1016/j.ijbiomac.2022.12.102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2022.12.102</ArticleId><ArticleId IdType="pubmed">36529220</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller VDM, Russo RR, Oliveira Cintra AC, Sartim MA, de Melo Alves-Paiva R, Figueiredo LTM, Sampaio SV, Aquino VH. Crotoxin and phospholipases A2 from Crotalus durissus terrificus showed antiviral activity against dengue and yellow fever viruses. Toxicon. 2012;59:507–515. doi: 10.1016/j.TOXICON.2011.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.TOXICON.2011.05.021</ArticleId><ArticleId IdType="pubmed">21723310</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki RF, Gill DM. A micro-biuret method for estimating proteins. Anal Biochem. 1964 doi: 10.1016/0003-2697(64)90200-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-2697(64)90200-3</ArticleId><ArticleId IdType="pubmed">14239476</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomonte B, Gutiérrez J, Furtado M, Otero R, Rosso J-P, Vargas O, Carmona E, Rovira ME. Isolation of basic myotoxins from Bothrops moojeni and Bothrops atrox snake venoms. Toxicon. 1990;28:1137–1146. doi: 10.1016/0041-0101(90)90114-M.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0041-0101(90)90114-M</ArticleId><ArticleId IdType="pubmed">2124735</ArticleId></ArticleIdList></Reference><Reference><Citation>Amorim F, Menaldo D, Carone S, Silva T, Sartim M, de Pauw E, Quinton L, Sampaio S. New insights on Moojase, a thrombin-like serine protease from Bothrops moojeni snake venom. Toxins. 2018;10:500. doi: 10.3390/toxins10120500.Basel.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins10120500.Basel</ArticleId><ArticleId IdType="pmc">PMC6316876</ArticleId><ArticleId IdType="pubmed">30487389</ArticleId></ArticleIdList></Reference><Reference><Citation>Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. doi: 10.1038/227680a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/227680a0</ArticleId><ArticleId IdType="pubmed">5432063</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingston NJ, Grehan K, Snowden JS, Shegdar M, Fox H, Macadam AJ, Rowlands DJ, Stonehouse NJ. Development of an enzyme-linked immunosorbent assay for detection of the native conformation of enterovirus A71. MSphere. 2022;7 doi: 10.1128/msphere.00088-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/msphere.00088-22</ArticleId><ArticleId IdType="pmc">PMC9241546</ArticleId><ArticleId IdType="pubmed">35642505</ArticleId></ArticleIdList></Reference><Reference><Citation>Hierholzer Killington. Virology Methods Manual. 1996</Citation></Reference><Reference><Citation>de Oliveira DM, Santos IdeA, Martins DOS, Gonçalves YG, Cardoso-Sousa L, Sabino-Silva R, von Poelhsitz G, Franca EdeF, Nicolau-Junior N, Pacca CC, Harris M, et al. Organometallic complex strongly impairs chikungunya virus entry to the host cells. Front Microbiol. 2020;11 doi: 10.3389/fmicb.2020.608924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.608924</ArticleId><ArticleId IdType="pmc">PMC7769844</ArticleId><ArticleId IdType="pubmed">33384677</ArticleId></ArticleIdList></Reference><Reference><Citation>Esquezaro PG, Manzano CM, Nakahata DH, Santos IA, Ruiz UEA, Santiago M, Silva NBS, Martins CHG, Pereira DH, Bergamini FRG, Jardim ACG, et al. spectroscopic characterization and in vitro antibacterial and antiviral activities of novel silver(I) complexes with mafenide and ethyl-mafenide. J Mol Struct. 2021;1246:131261. doi: 10.1016/j.molstruc.2021.131261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molstruc.2021.131261</ArticleId></ArticleIdList></Reference><Reference><Citation>Song JH, Yeo SG, Hong EH, Lee BR, Kim JW, Kim JH, Jeong HG, Kwon YS, Kim HP, Lee S, Park JH, et al. Antiviral activity of hederasaponin B from Hedera helix against enterovirus 71 subgenotypes c3 and C4a. Biomol Ther. 2014;22:41–46. doi: 10.4062/biomolther.2013.108.Seoul.</Citation><ArticleIdList><ArticleId IdType="doi">10.4062/biomolther.2013.108.Seoul</ArticleId><ArticleId IdType="pmc">PMC3936428</ArticleId><ArticleId IdType="pubmed">24596620</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomonte B, Gutiérrez J, Furtado M, Otero R, Rosso J-P, Vargas O, Carmona E, Rovira ME. Isolation of basic myotoxins from Bothrops moojeni and Bothrops atrox snake venoms. Toxicon. 1990;28:1137–1146. doi: 10.1016/0041-0101(90)90114-M.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0041-0101(90)90114-M</ArticleId><ArticleId IdType="pubmed">2124735</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974 doi: 10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Krug N, Hohlfeld JM, Aliprantis A, Carayannopoulos L, Bautmans A, Robberechts M, de Lepeleire I, Ziehr H, Singh D, Diamant Z, Yang S, et al. Rhinovirus challenge in asthmatics and healthy volunteers to evaluate the safety and appropriate dose of a GMP human rhinovirus 16 preparation for challenge studies in mild-moderate asthmatics taking ICS. Airway Pharmacology And Treatment, European Respiratory Society. 2018:PA4406. doi: 10.1183/13993003.congress-2018.PA4406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.congress-2018.PA4406</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Enterovirus. 2018;71</Citation></Reference><Reference><Citation>Wang Y, Zou G, Xia A, Wang X, Cai J, Gao Q, Yuan S, He G, Zhang S, Zeng M, Altmeyer R. Enterovirus 71 infection in children with hand, foot, and mouth disease in Shanghai, China: epidemiology, clinical feature and diagnosis positive-strand RNA viruses. Virol J. 2015 doi: 10.1186/s12985-015-0308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0308-2</ArticleId><ArticleId IdType="pmc">PMC4464242</ArticleId><ArticleId IdType="pubmed">26036928</ArticleId></ArticleIdList></Reference><Reference><Citation>Puenpa J, Wanlapakorn N, Vongpunsawad S, Poovorawan Y. The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia-Pacific region. J Biomed Sci. 2019;26:1–11. doi: 10.1186/s12929-019-0573-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0573-2</ArticleId><ArticleId IdType="pmc">PMC6798416</ArticleId><ArticleId IdType="pubmed">31627753</ArticleId></ArticleIdList></Reference><Reference><Citation>Petricevich VL, Mendonça RZ. Inhibitory potential of Crotalus durissus terrificus venom on measles virus growth. Toxicon. 2003;42:143–153. doi: 10.1016/S0041-0101(03)00124-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0041-0101(03)00124-7</ArticleId><ArticleId IdType="pubmed">12906885</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Wang JH, Lee WH, Wang Q, Liu H, Zheng YT, Zhang Y. Molecular characterization of Trimeresurus stejnegeri venom L-amino acid oxidase with potential anti-HIV activity. Biochem Biophys Res Commun. 2003;309:598–604. doi: 10.1016/j.bbrc.2003.08.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2003.08.044</ArticleId><ArticleId IdType="pubmed">12963032</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos IA, Shimizu JF, de Oliveira DM, Martins DOS, Cardoso-Sousa L, Cintra ACO, Aquino VH, Sampaio SV, Nicolau-Junior N, Sabino-Silva R, Merits A, et al. Chikungunya virus entry is strongly inhibited by phospholipase A2 isolated from the venom of Crotalus durissus terrificus. Sci Rep. 2021;11:1–12. doi: 10.1038/s41598-021-88039-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88039-4</ArticleId><ArticleId IdType="pmc">PMC8062466</ArticleId><ArticleId IdType="pubmed">33888774</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu JF, Pereira CM, Bittar C, Batista MN, Capos GRF, da Silva S, Cintra ACO, Zother C, Harris M, Sampaio SV, Aquino VH, et al. Multiple effects of toxins isolated from Crotalus durissus terrificus on the hepatitis C virus life cycle multiple effects of toxins isolated from Crotalus durissus terrificus on the hepatitis C virus life cycle Jacqueline Farinha Shimizu 1, Mariana Nogu. PLoS One. 2017;12:1–19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5687739</ArticleId><ArticleId IdType="pubmed">29141010</ArticleId></ArticleIdList></Reference><Reference><Citation>Siniavin AE, Streltsova MA, Nikiforova MA, Kudryavtsev DS, Grinkina SD, Gushchin VA, Mozhaeva VA, Starkov VG, Osipov AV, Lummis SCR, Tsetlin VI, et al. Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2. Cell Mol Life Sci. 2021;78:7777–7794. doi: 10.1007/s00018-021-03985-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-021-03985-6</ArticleId><ArticleId IdType="pmc">PMC8554752</ArticleId><ArticleId IdType="pubmed">34714362</ArticleId></ArticleIdList></Reference><Reference><Citation>Strating JR, van Kuppeveld FJ. Viral rewiring of cellular lipid metabolism to create membranous replication compartments. Curr Opin Cell Biol. 2017 doi: 10.1016/j.ceb.2017.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2017.02.005</ArticleId><ArticleId IdType="pmc">PMC7127510</ArticleId><ArticleId IdType="pubmed">28242560</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CC, Tseng KH. Effect of crotamine, a toxin of South American rattlesnake venom, on the sodium channel of murine skeletal muscle. Br J Pharmacol. 1978;63:551–559. doi: 10.1111/j.1476-5381.1978.tb07811.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.1978.tb07811.x</ArticleId><ArticleId IdType="pmc">PMC1668090</ArticleId><ArticleId IdType="pubmed">667499</ArticleId></ArticleIdList></Reference><Reference><Citation>Radis-Baptista G, Kerkis I. Crotamine, a small basic polypeptide myotoxin from rattlesnake venom with cell-penetrating properties. Curr Pharm Des. 2011;17:4351–4361. doi: 10.2174/138161211798999429.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161211798999429</ArticleId><ArticleId IdType="pubmed">22204433</ArticleId></ArticleIdList></Reference><Reference><Citation>Yount NY, Kupferwasser D, Spisni A, Dutz SM, Ramjan ZH, Sharma S, Waring AJ, Yeaman MR. Selective reciprocity in antimicrobial activity versus cytotoxicity of hBD-2 and crotamine. Proc Natl Acad Sci. 2009 doi: 10.1073/pnas.0904465106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0904465106</ArticleId><ArticleId IdType="pmc">PMC2736466</ArticleId><ArticleId IdType="pubmed">19706485</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamane ES, Bizerra FC, Oliveira EB, Moreira JT, Rajabi M, Nunes GLC, De Souza AO, Da Silva IDCG, Yamane T, Karpel RL, Silva PI, et al. Unraveling the antifungal activity of a South American rattlesnake toxin crotamine. Biochimie. 2013;95:231–240. doi: 10.1016/j.biochi.2012.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2012.09.019</ArticleId><ArticleId IdType="pubmed">23022146</ArticleId></ArticleIdList></Reference><Reference><Citation>Peigneur S, Orts DJB, Prieto da Silva AR, Oguiura N, Boni-Mitake M, de Oliveira EB, Zaharenko AJ, de Freitas JC, Tytgat J. Crotamine pharmacology revisited: novel insights based on the inhibition of K V channels. Mol Pharmacol. 2012;82:90–96. doi: 10.1124/mol.112.078188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.112.078188</ArticleId><ArticleId IdType="pubmed">22498659</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues M, Santos A, De La Torre BG, Rádis-Baptista G, Andreu D, Santos NC. Molecular characterization of the interaction of crotamine-derived nucleolar targeting peptides with lipid membranes. Biochim Biophys Acta Biomembr. 1818;2012:2707–2717. doi: 10.1016/j.bbamem.2012.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2012.06.014</ArticleId><ArticleId IdType="pubmed">22749950</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi MAF, Nascimento FD, Kerkis A, Oliveira V, Oliveira EB, Pereira A, Rádis-Baptista G, Nader HB, Yamane T, Kerkis I, Tersariol ILS. Cytotoxic effects of crotamine are mediated through lysosomal membrane permeabilization. Toxicon. 2008;52:508–517. doi: 10.1016/j.toxicon.2008.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxicon.2008.06.029</ArticleId><ArticleId IdType="pubmed">18662711</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento FD, Hayashi MAF, Kerkis A, Oliveira V, Oliveira EB, Rádis-Baptista G, Nader HB, Yamane T, dos Santos Tersariol IL, Kerkis I. Crotamine mediates gene delivery into cells through the binding to heparan sulfate proteoglycans. J Biol Chem. 2007;282:21349–21360. doi: 10.1074/jbc.M604876200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M604876200</ArticleId><ArticleId IdType="pubmed">17491023</ArticleId></ArticleIdList></Reference><Reference><Citation>Stábeli RG, Amui SF, Sant’Ana CD, Pires MG, Nomizo A, Monteiro MC, Romão PRT, Guerra-Sá R, Vieira CA, Giglio JR, Fontes MRM, et al. Bothrops moojeni myotoxin-II, a Lys49-phospholipase A2 homologue: an example of function versatility of snake venom proteins. Comp Biochem Physiol C: Toxicol Pharmacol. 2006;142:371–381. doi: 10.1016/j.cbpc.2005.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbpc.2005.11.020</ArticleId><ArticleId IdType="pubmed">16442348</ArticleId></ArticleIdList></Reference><Reference><Citation>Stábeli RG, Amui SF, Sant’Ana CD, Pires MG, Nomizo A, Monteiro MC, Romão PRT, Guerra-Sá R, Vieira CA, Giglio JR, Fontes MRM, et al. Bothrops moojeni myotoxin-II, a Lys49-phospholipase A2 homologue: an example of function versatility of snake venom proteins. Comp Biochem Physiol C: Toxicol Pharmacol. 2006;142:371–381. doi: 10.1016/j.cbpc.2005.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbpc.2005.11.020</ArticleId><ArticleId IdType="pubmed">16442348</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallacci M, Cavalcante WLG. Understanding the in vitro neuromuscular activity of snake venom Lys49 phospholipase A2 homologues. Toxicon. 2010;55:1–11. doi: 10.1016/j.toxicon.2009.10.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxicon.2009.10.025</ArticleId><ArticleId IdType="pubmed">19874839</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia-de-Sá P, Noronha-Matos JB, Timóteo MA, Ferreirinha F, Marques P, Soares AM, Carvalho C, Cavalcante WLG, Gallacci M. Bothropstoxin-I reduces evoked acetylcholine release from rat motor nerve terminals: radiochemical and real-time video-microscopy studies. Toxicon. 2013;61:16–25. doi: 10.1016/j.toxicon.2012.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxicon.2012.10.014</ArticleId><ArticleId IdType="pubmed">23142504</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Li Y, Li J. Dysregulated autophagy contributes to the pathogenesis of enterovirus A71 infection. Cell Biosci. 2020;10:142. doi: 10.1186/s13578-020-00503-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-020-00503-2</ArticleId><ArticleId IdType="pmc">PMC7724827</ArticleId><ArticleId IdType="pubmed">33298183</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossmann MG, He Y, Kuhn RJ. Picornavirus-receptor interactions. Trends Microbiol. 2002 doi: 10.1016/S0966-842X(02)02383-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0966-842X(02)02383-1</ArticleId><ArticleId IdType="pubmed">12110211</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Peng W, Ren J, Hu Z, Xu J, Lou Z, Li X, Yin W, Shen X, Porta C, Walter TS, et al. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol. 2012;19:424–429. doi: 10.1038/nsmb.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2255</ArticleId><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Peng W, Ren J, Hu Z, Xu J, Lou Z, Li X, Yin W, Shen X, Porta C, Walter TS, et al. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol. 2012;19:424–429. doi: 10.1038/nsmb.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2255</ArticleId><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>